Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 215,258,115 papers from all fields of science
Search
Sign In
Create Free Account
methanesulfonic acid, potassium salt
Known as:
potassium mesylate
, potassium methanesulfonate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
methanesulfonic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Synthesis of oxazolidinones: rhodium-catalyzed C-H amination of N-mesyloxycarbamates.
H. Lebel
,
Laura Mamani Laparra
,
+6 authors
M. Ernzerhof
Organic and biomolecular chemistry
2017
Corpus ID: 206113585
N-Mesyloxycarbamates undergo intramolecular C-H amination reactions to afford oxazolidinones in good to excellent yields in the…
Expand
2011
2011
New automated synthesis of [18F]FP-CIT with base amount control affording high and stable radiochemical yield: a 1.5-year production report.
Sang Ju Lee
,
S. Oh
,
+5 authors
J. Ryu
Nuclear Medicine and Biology
2011
Corpus ID: 32245203
Highly Cited
1994
Highly Cited
1994
Whole-cell recording of the Ca2+-dependent slow afterhyperpolarization in hippocampal neurones: effects of internally applied anions
L. Zhang
,
J. Weiner
,
+6 authors
P. Carlen
Pflügers Archiv
1994
Corpus ID: 8879017
Using the whole-cell recording technique, we have examined the slow Ca2+-activated afterhyperpolarization (AHP) and its…
Expand
1993
1993
Influence of ionic strength on contractile force and energy consumption of skinned fibers from mammalian and crustacean striated muscle.
R. Godt
,
R. Fogaça
,
M. Andrews
,
T. Nosek
Advances in Experimental Medicine and Biology
1993
Corpus ID: 19346948
Increased ionic strength decreases maximal calcium-activated force (Fmax) of skinned muscle fibers via mechanisms that are…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE